Revelation Biosciences In... (REVBW)
NASDAQ: REVBW
· Real-Time Price · USD
0.01
-0.00 (-10.71%)
At close: Jun 09, 2025, 2:31 PM
Revelation Biosciences Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -8.17M | -7.98M | -8.55M | -9.53M | -8.94M | -8.66M | -7.55M | -5.97M | -5.9M | -10.86M | -13.5M | -15.35M | -15.93M | -11.95M | -10.99M | -7.95M | -5.67M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 28.73K | 28.73K | 28.73K | 28.73K | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -14.41M | -15.04M | -15.52M | -15.9M | -8.96M | -120.25K | 875.06K | 2.33M | 1.95M | -10.83M | -13.48M | -15.36M | -15.99M | -11.99M | -11.02M | -7.98M | -5.67M |
Net Income | -14.41M | -15.04M | -15.52M | -15.9M | -8.96M | -120.25K | 875.06K | 2.33M | 1.95M | -10.83M | -13.48M | -15.36M | -15.99M | -11.99M | -11.02M | -7.98M | -5.67M |
Selling & General & Admin | 4.48M | 4.43M | 4.54M | 4.7M | 4.6M | 4.51M | 4.12M | 3.81M | 3.68M | 5.49M | 5.8M | 6.49M | 6.89M | 5.04M | 4.72M | 3.21M | 2M |
Research & Development | 3.69M | 3.55M | 4M | 4.82M | 4.34M | 4.15M | 3.43M | 2.16M | 2.22M | 5.38M | 7.7M | 8.85M | 9.04M | 6.91M | 6.27M | 4.74M | 3.67M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 8.17M | 7.98M | 8.55M | 9.53M | 8.94M | 8.66M | 7.55M | 5.97M | 5.9M | 10.86M | 13.5M | 15.35M | 15.93M | 11.95M | 10.99M | 7.94M | 5.67M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 557.00 | 557.00 | 557.00 | 557.00 | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 8.17M | 7.98M | 8.55M | 9.53M | 8.94M | 8.66M | 7.55M | 5.97M | 5.9M | 10.86M | 13.5M | 15.35M | 15.93M | 11.95M | 10.99M | 7.94M | 5.67M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 126.00 | -52.62K | -52.62K |
Shares Outstanding (Basic) | 971.31K | 346.5K | 2.68M | 1.64M | 1.09M | 264.54K | 209.91K | 193.74K | 73.69K | 22.76K | 20.05K | 14.36K | 13.53K | 7.94K | 8.66K | 8.66K | 8.66K |
Shares Outstanding (Diluted) | 971.31K | 346.5K | 2.68M | 1.64M | 1.09M | 264.54K | 209.91K | 193.74K | 104.53K | 22.76K | 20.05K | 14.36K | 13.53K | 7.94K | 8.66K | 8.66K | 8.66K |
EPS (Basic) | -9.09 | -9.44 | -16.76 | -28.44 | -30.78 | 160.83 | 116.38 | 71.95 | -46.52 | -727.11 | -1.16K | -1.46K | -1.61K | -1.42K | -1.27K | -920.71 | -654.51 |
EPS (Diluted) | -9.09 | -9.44 | -16.76 | -28.44 | -30.78 | 105.02 | 60.57 | 16.14 | -102.33 | -727.11 | -1.16K | -1.46K | -1.61K | -1.42K | -1.27K | -920.71 | -654.51 |
EBITDA | -8.14M | -7.95M | -8.52M | -9.5M | -8.91M | -8.63M | -7.52M | -5.95M | -5.87M | -10.84M | -13.48M | -15.32M | -15.91M | -11.93M | -8.08M | -5.05M | -2.44M |
EBIT | -8.17M | -7.98M | -8.55M | -9.53M | -8.94M | -8.66M | -7.55M | -5.97M | -5.9M | -10.86M | -13.5M | -15.35M | -15.93M | -11.95M | -9.72M | -6.67M | -4.23M |
Depreciation & Amortization | 28.88K | 27.92K | 26.96K | 26.01K | 25.05K | 25.05K | 25.05K | 25.05K | 25.05K | 25.05K | 25.05K | 24.86K | 22.4K | 16.78K | 2.91M | 2.95M | 3.11M |